whole-gland
Showing 1 - 25 of 5,723
Prostate Cancer Recurrent Trial in Toronto (HDR brachytherapy)
Active, not recruiting
- Prostate Cancer Recurrent
- HDR brachytherapy
-
Toronto, Ontario, CanadaOdette Cancer Centre, Sunnybrook Health Sciences Centre
May 3, 2022
Prostate Cancer Trial in Toronto (targeted focal HDR brachytherapy, Whole-gland HDR Brachytherapy)
Recruiting
- Prostate Cancer
- targeted focal HDR brachytherapy
- Whole-gland HDR Brachytherapy
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Oct 4, 2021
Carcinoma Prostate Trial in Toronto (LDR/HDR)
Terminated
- Carcinoma Prostate
- LDR/HDR
-
Toronto, Ontario, CanadaSunnybrook Odette Cancer Centre
Apr 23, 2021
Prostate Cancer Trial in Toronto (MR-guided Radiotherapy Boost)
Not yet recruiting
- Prostate Cancer
- MR-guided Radiotherapy Boost
-
Toronto, Ontario, CanadaUniversity Health Network, Princess Margaret Hospital
Oct 6, 2022
Prostate Cancer Trial in Toronto (MRI assisted focal boost with HDR monotherapy)
Active, not recruiting
- Prostate Cancer
- MRI assisted focal boost with HDR monotherapy
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Jun 12, 2022
Immune Biomarker Study for Salivary Gland Carcinoma
Not yet recruiting
- Salivary Gland Tumor
- Benign Salivary Gland Tumor
- Sampling
-
Erlangen, Bavaria, Germany
- +1 more
Sep 21, 2023
A Modified Calculation Formula for Meibomian Gland Grading
Completed
- Meibomian Gland Dysfunction
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Oct 27, 2023
Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,
Not yet recruiting
- Localized Prostate Carcinoma
- +3 more
- Degarelix
- MRI-guided transurethral ultrasound ablation (TULSA)
-
Turku, Southwest Finland, FinlandTurku University Hospital
Jun 14, 2023
Exercise in Heat in Cystic Fibrosis on Modulator Therapy.
Recruiting
- Cystic Fibrosis
-
Portsmouth, United KingdomUniversity of Portsmouth
May 31, 2023
Prostatic Tumors, Prostate Cancer, Prostate Adenocarcinoma Trial run by the National Cancer Institute (NCI) (18F-DCFPyL,
Not yet recruiting
- Prostatic Neoplasms
- +2 more
- 18F-DCFPyL
- Stereotactic Body Radiation Therapy
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Xerostomia Trial (Mesenchymal stem cell, Isotonic NaCl)
Completed
- Xerostomia
- Mesenchymal stem cell
- Isotonic NaCl
- (no location specified)
Nov 24, 2022
Head Neck Cancer Trial in Groningen (Submandibular Gland Stem Cell Transplantation)
Recruiting
- Head and Neck Cancer
- Submandibular Gland Stem Cell Transplantation
-
Groningen, NetherlandsUMCG
May 24, 2022
Xerostomia Following Radiotherapy Trial in Ljubljana (allogeneic mesenchymal stromal stem cells)
Not yet recruiting
- Xerostomia Following Radiotherapy
- allogeneic mesenchymal stromal stem cells
-
Ljubljana, Slovenia
- +3 more
Aug 22, 2023
AAV2hAQP1 for Radiation Induced Xerostomia
Enrolling by invitation
- Radiation-induced Xerostomia
-
Stanford, California
- +3 more
Dec 22, 2022
Dry Eye Syndromes, Meibomian Gland Dysfunction Trial (Actual IPL, Sham IPL, LLLT)
Not yet recruiting
- Dry Eye Syndromes
- Meibomian Gland Dysfunction
- Actual IPL
- +2 more
- (no location specified)
Aug 21, 2023
Characterization of Prostate Cancer With 3T MR
Active, not recruiting
- Prostate Cancer
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 26, 2023
Primary Sjogren's Syndrome Trial in Palo Alto (tibulizumab (LY3090106))
Withdrawn
- Primary Sjogren's Syndrome
- tibulizumab (LY3090106)
-
Palo Alto, CaliforniaStanford University
Jan 12, 2022
Radiotracer, Hypertension, Cholesterol Trial in Ann Arbor (Dexamethasone (Group 2), Cosyntropin (Group 3), PET/CT Scan with
Recruiting
- Radiotracer
- +2 more
- Dexamethasone (Group 2)
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan
Dec 9, 2022
Rheumatoid Arthritis, Sjogren's Syndrome, Sicca, Asthenia, Polyalgia Syndrome (SAPS) Trial in Clermont-Ferrand (Ultrasound of
Recruiting
- Rheumatoid Arthritis
- +2 more
- Ultrasound of the salivary glands
- +2 more
-
Clermont-Ferrand, FranceCHU de Clermont-Ferrand
Mar 22, 2023
Penn SICCA Follow-up Study
Not yet recruiting
- Dry Eye
- Sjogren's Syndrome
-
Philadelphia, PennsylvaniaScheie Eye Institute
Jan 7, 2022
Pituitary Tumors and Related Hypothalmic Disorders
Recruiting
- Panhypopituitarism
- +3 more
- MRI
- Tissue specimen collection
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Systemic Sclerosis Trial in Brest, Rennes, Tours (Minor Salivary gland Biopsy, ARFI, MSG US)
Completed
- Systemic Sclerosis
- Minor Salivary gland Biopsy
- +2 more
-
Brest, France
- +2 more
Apr 4, 2022
Prostate Cancer Trial (Radiotherapy standard, Radiotherapy Hypo-FLAME)
Not yet recruiting
- Prostate Cancer
- Radiotherapy standard
- Radiotherapy Hypo-FLAME
- (no location specified)
Jan 30, 2023
CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer
Enrolling by invitation
- Thyroid Cancer
-
Cleveland, OhioCleveland Clinic
Aug 9, 2021
Carcinoma of Prostate Trial in Toronto (18F-DCFPyL)
Active, not recruiting
- Carcinoma of Prostate
- 18F-DCFPyL
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Oct 31, 2022